Pfizer (PFE) CEO Isn’t Ready For A Fight With RFK Jr., Says Jim Cramer

We recently published 10 Stocks Jim Cramer Talked About.  Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer talked about. Pharma giant Pfizer Inc. (NYSE:PFE)’s shares are down by 4.7% over the past year and flat year-to-date. UBS initiated coverage of the stock in January as it set a Neutral rating for the shares and a $25 share price target. UBS explained that between $15 billion to $20 billion in Pfizer Inc. (NYSE:PFE)’s revenue is tied to drugs that will lose patent protection over the next thr ...